Dutch enforcer closes abuse probe into Pfizer
Shutterstock/Maarten Zeehandelaar
Pfizer has agreed to stop its exclusivity-based discount system for the provision of a drug supplied to hospitals for treating autoimmune diseases in order to end an abuse of dominance investigation by the Dutch competition authority.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now